[HTML][HTML] A review: Brief insight into Polycystic Ovarian syndrome

J Bulsara, P Patel, A Soni, S Acharya - Endocrine and metabolic science, 2021 - Elsevier
Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder with the
underline indication of ovarian cysts, anovulation, and endocrine variation affecting the …

Polycystic ovary syndrome

R Azziz, E Carmina, ZJ Chen, A Dunaif… - Nature reviews Disease …, 2016 - nature.com
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …

Polycystic ovary syndrome

R Norman, R Wu, M Stankiewicz - 2004 - digital.library.adelaide.edu.au
Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …

[HTML][HTML] Poly cystic ovarian syndrome: an updated overview

S El Hayek, L Bitar, LH Hamdar, FG Mirza… - Frontiers in …, 2016 - frontiersin.org
Poly Cystic Ovarian Syndrome (PCOS) is one of the most common metabolic and
reproductive disorders among women of reproductive age. Women suffering from PCOS …

The pathogenesis and treatment of polycystic ovary syndrome: What's new?

S Bednarska, A Siejka - Advances in Clinical and …, 2017 - publicum.umed.lodz.pl
Polycystic ovary syndrome (PCOS) is currently the leading cause of menstrual complications
in women. It is characterized by clinical and/or biochemical hyperandrogenism, ovulation …

[HTML][HTML] Polycystic ovary syndrome: current status and future perspective

EK Barthelmess, RK Naz - Frontiers in bioscience (Elite edition), 2014 - ncbi.nlm.nih.gov
Polycystic ovary syndrome (PCOS) is a widespread reproductive disorder that encompasses
many associated health conditions and has an impact on various metabolic processes …

[PDF][PDF] The pathophysiology of polycystic ovary syndrome

T Tsilchorozidou, C Overton, GS Conway - Clinical endocrinology, 2004 - academia.edu
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of uncertain aetiology,
which affects between 6 and 10% of women of the reproductive age. The heterogeneity of …

[HTML][HTML] Recent advances in the understanding and management of polycystic ovary syndrome

AL Rocha, FR Oliveira, RC Azevedo, VA Silva… - …, 2019 - ncbi.nlm.nih.gov
Polycystic ovary syndrome (PCOS) is a multifaceted condition characterized by chronic
anovulation and excess ovarian activity, in contrast to other causes of anovulation that …

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

Polycystic ovary syndrome

R Homburg - Best Practice & Research Clinical Obstetrics & …, 2008 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common female endocrinopathy, affecting 5–
10% of the female population. It involves overproduction of ovarian androgens leading to a …